Inclusion criteria (let op korte versie, zie full protocol voor details)
Male or female, aged 18 years or above
Scheduled to receive one of the following two therapeutic strategies: Concurrent chemotherapy and radiotherapy with photons (60 Gy in 30 fractions of 2 Gy) in patients with stage III NSCLC Concurrent chemotherapy and radiotherapy with protons (60 Gy in 30 fractions of 2 Gy) in patients with stage III NSCLC
Key exclusion criteria
Exclusion criteria
Mixed non-small cell lung cancer with other histologies such as small cell lung cancer
Not able to comply with the study protocol
Previous radiotherapy to the chest for benign or malignant conditions, including radiation for breast cancer
Previous malignancy treated with chemotherapy, immune therapy or radiotherapy (irrespective of when this happened)
Previous malignancies treated with surgery only are allowed if 2 years or more before inclusion in the present study
Wij maken op deze website gebruik van cookies om het gebruik van de website te
vergemakkelijken, de prestaties en gebruikerservaring te verbeteren en de
relevantie van het aanbod op deze website te verhogen.
Lees ons Cookies &
Privacystatement.